Home > Insider Trading > Filing (0001144204-13-013905)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
911148	Cadus Corp	KDUS	Biological Products, (No Disgnostic Substances) (2836)	133660391

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1377817	Moab Capital Partners Llc	152 East 62Nd Street New York NY 10065	No	No	Yes	No
1393832	Michael Rothenberg	152 East 62Nd Street New York NY 10065	No	No	Yes	No
1393833	Moab Gp Llc	152 East 62Nd Street New York NY 10065	No	No	Yes	No
1393834	Moab Partners Lp	152 East 62Nd Street New York NY 10065	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-03-06	250,000	$1.43	1,469,350	No	4	S	Indirect	Performance related fees

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Performance related fees

Footnotes

The securities are owned directly by Moab Partners, L.P. (the "Fund"). Moab Capital Partners, LLC ("Moab LLC") is the investment adviser to the Fund and may be deemed to beneficially own the securities under Section 13(d) of the Securities Exchange Act of 1934 (the "Exchange Act") . Moab GP, LLC ("Moab GP") is the general partner of the Fund and may be deemed to beneficially own the securities under Section 13(d) of the Exchange Act. Michael M. Rothenberg is the Managing Member of Moab LLC and Moab GP and may also be deemed to beneficially own the securities under Section 13(d) of the Exchange Act. Moab LLC, Moab GP and Mr. Rothenberg disclaim beneficial ownership of the securities for purposes of Section 16 of the Exchange Act, except the extent of their pecuniary interest in the securities.